Stock BLUE BLUEBIRD BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News bluebird bio, Inc.

Equities

BLUE

US09609G1004

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
0.953 USD -1.07% Intraday chart for bluebird bio, Inc. -17.84% -30.94%
Mar. 27 Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating MT
Mar. 27 Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
PR
ROSEN, NATIONAL TRIAL LAWYERS, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
PR
May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUE
PR
Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law Firm
PR
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
PR
Bluebird bio, Inc. Class Action: Levi & Korsinsky Reminds bluebird bio Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 28, 2024 - BLUE
PR
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation - BLUE
PR
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against BlueBird Bio, Inc. (NASDAQ: BLUE)
BU
BLUE Shareholders with Significant Losses are Urged to Contact Robbins LLP to Discuss the bluebird bio, Inc. Class Action
BU
Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio, Inc. - BLUE
PR
Bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)
AQ
Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
PR
Bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
ROSEN, A TOP RANKED LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
PR
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
PR
May 28, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against BLUE
PR
BLUE Robbins Geller Rudman & Dowd LLP Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BU
Bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUE
PR
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio Lawsuit - BLUE
PR
BLUE Bronstein, Gewirtz & Grossman LLC Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BLUE Stock
  4. News bluebird bio, Inc.